Acne Medication

Acne Medication Market Insights

Market Overview:

The rising prevalence of acne-related disorders is expected to propel market growth over the forecast period. Acne, for example, is the most common skin condition in the United States, affecting approximately 50 million people annually, according to data provided by the American Academy of Dermatology Association in 2021. Furthermore, approximately 85% of people aged 12 to 24 have at least minor acne. The market's expanding robust pipeline of acne medications is expected to drive market growth over the forecast period. For instance, Bausch Health Companies Inc., a global healthcare company, and Ortho Dermatologics, one of the major prescription dermatological health care companies, announced statistically significant topline results from a second pivotal Phase 3 clinical trial evaluating IDP-126, a combination retinoid, anti-bacterial, and antibiotic topical, to treat acne vulgaris in patients nine years of age and older. IDP-126, if approved, would be the first of its kind to use this triple combination.

Get more info about Acne Medication- https://www.skyquestt.com/report/acne-medication-market

Analysis:

Segmentation Analysis:

The Acne Medication Market is segmented by Therapeutic Class, Formulation, Type, Acne Type, Distribution Channel, Region. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

Regional Analysis:

Acne Medication Market is being analyzed by North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA) regions. Key countries including the U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, and South Africa among others were analyzed considering various micro and macro trends.

Risk Analysis:

SkyQuest's expert analysts have conducted a risk analysis to understand the impact of external extremities on Acne Medication Market. We analyzed how geopolitical influence, natural disasters, climate change, legal scenario, economic impact, trade & economic policies, social & ethnic concerns, and demographic changes might affect Acne Medication Market's supply chain, distribution, and total revenue growth.

Key Players Covered in the Report:

Almirall SA.
Bausch Health Companies Inc.
GlaxoSmithKline Plc (GSK)
Johnson & Johnson
Galderma S.A
Mayne Pharma Group Limited
Mylan N.V.
Pfizer Inc.
Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd.

About Us:

SkyQuest Technology is leading growth consulting firm providing market
intelligence, commercialization and technology services. It has 450+ happy clients
globally.

Address:

1 Apache Way, Westford, Massachusetts 01886
Phone:
USA (+1) 617-230-0741
Email: sales@skyquestt.com